ICL (ICL) – StreetInsider.com Reports
-
Israel Chemicals Ltd (ICL) PT Lowered to $5.20 at Morgan Stanley
-
Israel Chemicals Ltd (ICL) PT Lowered to $5.25 at Morgan Stanley
-
Israel Chemicals Ltd (ICL) PT Raised to $4.50 at Barclays
-
ICL (ICL) Tops Q4 EPS by 2c; offers guidance
-
ICL (ICL) Acquires Nitro 1000
-
Israel Chemicals Ltd (ICL) PT Lowered to $6 at BMO Capital
-
Barclays Downgrades Israel Chemicals Ltd (ICL) to Underweight
-
Barclays Upgrades Israel Chemicals Ltd (ICL) to Overweight
-
ICL (ICL) Tops Q3 EPS by 1c; Offers guidance
-
Israel Chemicals Ltd (ICL) PT Lowered to $6.25 at BMO Capital
-
ICL (ICL) Breaks Ground on $400M Battery Materials Manufacturing Plant in St. Louis
-
ICL (ICL) Misses Q2 EPS by 2c
-
ICL (ICL) Provides Updates on Chinese Potash Agreement and 2023 EBITDA Guidance
-
Israel Chemicals Ltd (ICL) PT Lowered to $7 at Morgan Stanley
-
BofA Securities Downgrades Israel Chemicals Ltd (ICL) to Neutral
-
Israel Chemicals Ltd (ICL) PT Lowered to $8 at BMO Capital
-
Israel Chemicals Ltd (ICL) PT Lowered to $8 at Barclays
-
Israel Chemicals Ltd (ICL) PT Lowered to $7.50 at Morgan Stanley
-
Israel Chemicals Ltd (ICL) PT Lowered to $9 at BMO Capital
-
Israel Chemicals Ltd (ICL) PT Lowered to $10 at Barclays
-
ICL (ICL) Invests EUR 2.75M in Arkeon
-
Israel Chemicals Ltd (ICL) PT Lowered to $11 at Barclays
-
Israel Chemicals Ltd (ICL) PT Lowered to $9.50 at BMO Capital
-
ICL (ICL) and Evogene's (EVGN) Lavie Bio Collaborate to Develop Novel Bio-Stimulant Products
-
ICL (ICL) Enters MoU with Aleees for Production of Lithium Iron Phosphate Battery Cathode Materials
-
Barclays Assumes Israel Chemicals Ltd (ICL) at Equalweight
-
Israel Chemicals Ltd (ICL) PT Raised to $12 at Morgan Stanley
-
Israel Chemicals Ltd (ICL) PT Raised to $10 at Morgan Stanley
-
ICL (ICL) Reports Q4 Sales of $2.04B, EPS of $0.26
-
Israel Chemicals Ltd (ICL) PT Raised to $9 at Morgan Stanley
-
ICL (ICL) CFO to Step Down
-
ICL's (ICL) Polysulphate Fertilizer Receives Organic Certifications
-
Israel Chemicals Ltd (ICL) PT Raised to $7 at Morgan Stanley
-
Compass Minerals (CMP) to Sell South America Specialty Plant Nutrition Business for $418 Million
-
ICL (ICL) Reports Acquisition of South American Plant Nutrition Business from Compass Minerals (CMP) for $402M
-
ICL (ICL) Announces Strategic Additions to Executive Leadership and Board of Directors
-
Israel Chemicals Ltd (ICL) PT Raised to $6 at Morgan Stanley
-
Israel Chemicals Ltd (ICL) PT Raised to $5 at Morgan Stanley
-
ICL (ICL) Announces Private Offering of Additional $93.1 Million Senior Notes
-
Stephens Downgrades Israel Chemicals Ltd (ICL) to Equal Weight
-
Israel Chemicals Ltd (ICL) PT Raised to $4.50 at Barclays
-
ICL (ICL) Reports Acquisition of Fertilaqua
-
Israel Chemicals Ltd (ICL) PT Lowered to $3.50 at BMO Capital
-
ICL (ICL) Reports In-Line Q4 EPS
-
Israel Chemicals Ltd (ICL) PT Lowered to $5 at Morgan Stanley
-
Barclays Starts Israel Chemicals Ltd (ICL) at Equalweight
-
Israel Chemicals Ltd (ICL) PT Lowered to $5.50 at BMO Capital
-
USDA Report Takes Bull Case Down a Notch - BMO
-
ICL Group (ICL) PT Raised to $5.75 at BMO Capital
-
Stephens Starts Israel Chemicals Ltd (ICL) at Overweight
Back to ICL Stock Lookup